InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Smith Mark Douglas, 董事. Director active across 3 companies, notably Teladoc Health, Inc.. Aggregated, 20 reports have been published. Split: 1 buy · 3 sells. Total volume traded: €178k. Activity tracked since 8 July 2021. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Smith Mark Douglas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
1,605 股0Ordinary SharesSEC:0001756253-26-000006:0
3,507 股0Ordinary SharesSEC:0001765581-25-000080:0
7,000 股@ US$4.7111.3% 占其流量Common StockSEC:0001127602-25-018936:0
6,700 股@ US$27.6172.4% 占其流量Common StockSEC:0001127602-25-018206:0
4,000 股@ US$7.078100.0% 占其流量Common StockSEC:0001628280-24-037693:0
标准退出：2024年11月13日 (T+90)
3,731 股0Ordinary SharesSEC:0001765581-24-000078:0
7,000 股@ US$4.7150.0% 占其流量Common StockSEC:0001127602-24-020800:0
8,490 股0Common StockSEC:0001127602-24-019403:0
417 股@ US$119.2723.2% 占其流量Ordinary SharesSEC:0001765581-23-000110:0
3,075 股0Ordinary SharesSEC:0001765581-23-000090:0
6,051 股0Common StockSEC:0001562180-23-005580:0
7,000 股@ US$4.7150.0% 占其流量Common StockSEC:0001562180-23-003442:0
420 股@ US$154.680631.4% 占其流量Ordinary SharesSEC:0001765581-22-000130:0
2,561 股0Ordinary SharesSEC:0001765581-22-000098:0
7,397 股0Common StockSEC:0001562180-22-005519:0
819 股Common StockSEC:0001415889-22-005235:0
417 股@ US$121.3029.4% 占其流量Ordinary SharesSEC:0001765581-21-000133:0
2,246 股0Ordinary SharesSEC:0001765581-21-000083:0
2,605 股0Common StockSEC:0001562180-21-004894:0
524 股Common StockSEC:0001179110-21-005495:0
20 条申报中的 20 条
About Smith Mark Douglas
Smith Mark Douglas is Administrateur at Jazz Pharmaceuticals plc, Phreesia, Inc. and Teladoc Health, Inc. Across 19 filings in total, the 19 sampled filings run from 2021-05-18 to 2025-08-11 and show EUR 25802 of buys and EUR 152070 of sells, with the dominant transaction nature listed as Attribution.
